SEAL @214 (99.6%) on 22-feb-2011 [ 12345678 ] using boston_scientific
CMC @1103 (100.0%) on 08-mar-2018 [ SUFFIX=ton 1.91977 FULL_POS=NN_JJ 1.72173 LASTSUFFIX=ic 1.47242 SUFFIX=on 1.39564 LAST_WORD=scientific 1.26901 LASTSUFFIX=tific 1.26901 SUFFIX=tific 1.22981 FULL_WORDSHAPE=a_a -0.49258 SUFFIX=ic -0.85304 WORDS -1.70373 ] using boston_scientific
CPL @1108 (65.9%) on 06-jun-2018 [ "pharmaceutical companies including _" "It acted for _" "_ 's non-GAAP net income" "_ made an equity investment" "equipment donation from _" "pharmaceutical companies such as _" "other factors described in _" "GE partnered with _" "honorarium from _" "global companies like _" "high-tech firms such as _" "_ were upgraded this morning" "trial was funded by _" "company , now owned by _" "multinational companies such as _" "patent held by _" "original employees at _" "stent from _" "speaking fees from _" "news developments at _" "Job cuts at _" "trial was supported by _" "_ received an approvable letter" "flow also surfaced in _" "stent made by _" "educational initiative sponsored by _" "Key players covered include _" "_ 's Jiibe" "trial is being sponsored by _" "device , manufactured by _" "significant shareholders of _" "clinical research associate at _" "companies worldwide such as _" "medical companies such as _" "medical device companies such as _" "medical device companies , including _" "volume was also seen in _" "_ is a worldwide developer" "recent news developments at _" "multinationals like _" "_ became a BCA company" "company , was acquired by _" "device companies such as _" "trial , sponsored by _" "_ 's DCF analysis" "majority-owned subsidiary of _" "Bearish flow also surfaced in _" "_ brought this motion" "grant support from _" "_ 's ongoing litigation" "Helpful Information for _" "biotechnology companies such as _" "senior medical director for _" "speaker honoraria from _" "_ announced FDA approval" "lecture fees from _" "stimulator from _" "consultancy fees from _" "Development positions at _" "unrestricted grant from _" "spinout from _" "national clients , including _" "Texas jury found _" "device companies including _" "company acquired by _" "product development positions at _" "_ 's DCF Analysis" "_ gets FDA OK" "Client companies include _" "_ manufactures medical equipment" "such major corporations as _" "Local companies include _" "_ 's equity research report" "business unit of _" "grant/research support from _" "_ 's Corporate Governance Guidelines" "_ is a free instance" "consulting fees from _" "trial was sponsored by _" "pharmaceutical companies , including _" "chief medical officer at _" "FDA has asked _" "Large firms like _" "lecture honoraria from _" "independent educational grant from _" "honoraria from _" "players covered include _" "pharmaceutical companies like _" "device companies , including _" "division president at _" "collaboration agreement with _" "research support from _" "_ anticipates FDA approval" "educational grant from _" "major businesses such as _" "engineering positions at _" "_ is a global developer" "speakersbureau for _" "_ gets FDA approval" "_ 's WACC calculation" "_ 's comparative multiple analysis" "startup was acquired by _" "System , manufactured by _" "large manufacturers like _" "defibrillators made by _" "_ 's overall business strategy" "future cash flows generated by _" "federal jury ordered _" "medical device companies including _" "medical device companies like _" "engineering intern at _" "company now owned by _" "medical instruments at _" "flows generated by _" "generous educational grant from _" "_ is a medical device manufacturer" ] using boston_scientific
SEAL @235 (98.4%) on 15-apr-2011 [ 123456 ] using boston_scientific_corporation
Human feedback from estevam @888 on 02-dec-2014 [ "boston_scientific generalizations company", Action=(+biotechcompany) (from NELL.08m.888.SSFeedback.csv) ] using boston_scientific
CMC @889 (100.0%) on 04-dec-2014 [ LAST_WORD=corporation 2.44820 LASTPREFIX=corpo 1.96791 SUFFIX=on 1.96655 PREFIX=corpo 1.96233 LASTPREFIX=corp 1.95623 PREFIX=cor 1.74740 LASTPREFIX=cor 1.66426 SUFFIX=ion -0.74660 SUFFIX=tion -1.08652 WORDS -2.05812 ] using boston_scientific_corporation
CPL @1105 (96.9%) on 25-mar-2018 [ "arg2 Corporation by arg1" "arg2 agreed to be acquired by arg1" "arg2 Corporation was acquired by arg1" "arg2 was acquired by arg1" "arg2 was recently acquired by arg1" ] using (boston_scientific, guidant)
CPL @1107 (50.0%) on 24-may-2018 [ "arg2 Corp by arg1" ] using (boston_scientific_corporation, guidant)
OE @820 (93.6%) on 06-mar-2014 [ ] using (boston_scientific, guidant)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" "Y~X0~concept:agentcontrols,concept:agenthierarchicallybelowagent,concept:agentcontrols" ] using (boston_scientific, guidant)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" "Y~X0~concept:agentcontrols,concept:agenthierarchicallybelowagent,concept:agentcontrols" ] using (guidant, boston_scientific)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" "Y~X0~concept:agentcontrols,concept:agenthierarchicallybelowagent,concept:agentcontrols" ] using (boston_scientific, guidant)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" "Y~X0~concept:agentcontrols,concept:agenthierarchicallybelowagent,concept:agentcontrols" ] using (guidant, boston_scientific)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcollaborateswithagent" "Y~_X0~concept:agentcollaborateswithagent" "Y~X0~concept:agentinteractswithagent" "Y~_X0~concept:agentinteractswithagent" "Y~X0~concept:superpartof" ] using (boston_scientific, guidant)
CPL @1095 (93.8%) on 17-jan-2018 [ "arg1 Corporation by arg2" "arg1 agreed to be acquired by arg2" "arg1 was acquired by arg2" "arg1 was recently acquired by arg2" ] using (guidant, boston_scientific)
NELL has only weak evidence for items listed in grey